New hope for tough depression: Real-World study tracks who benefits from esketamine
NCT ID NCT07146503
Summary
This study is observing how esketamine nasal spray works for people with severe, treatment-resistant depression in real-world clinics. It aims to see who benefits most from the treatment and how it affects their daily life, work, and social functioning. Researchers will also look for biological clues, like genetics, that might predict a good response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Fatebenefratelli Sacco
RECRUITINGMilan, 20157, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Csm Dds 8
RECRUITINGGenova, Ge, 16158, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ospedale Policlinico San Martino
RECRUITINGGenova, Ge, 16132, Italy
Contact Email: •••••@•••••
-
Università di Chieti
RECRUITINGChieti, 66100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.